Skip to main content
. 2022 Jan 3;24:340–354. doi: 10.1016/j.omto.2021.12.025

Figure 7.

Figure 7

Hypothetic model illustrating the antitumor research of Nar

(A) Predicting potential target of Nar. (B) Narciclasine targets STAT3 via distinct mechanisms in breast cancer MCF-7 and tamoxifen-resistant MCF-7 cells. (C) Nar-LPs suppress the growth of MCF-7/TR xenograft tumors.